Table 2.
Summary of clinical characteristics of all pooled patients.
| Characteristics | Value |
|---|---|
| Presenting Symptoms (n = 811) | No. (%) |
| Median duration, range (months) | 16, 0.1–312 |
| Diplopia | 237 (29.2%) |
| Headache | 177 (21.8%) |
| Vision Impairment | 64 (7.9%) |
| Hearing Loss | 41 (5.1%) |
| Hypopituitarism | 29 (3.6%) |
| Motor Deficits | 29 (3.6%) |
| Vertigo | 29 (3.6%) |
| Others | 69 (8.5%) |
| No Symptoms | 51 (6.3%) |
| Cranial Nerve Neuropathies (n = 810) | No. (%) |
| I | 3 (0.4%) |
| II | 28 (3.5%) |
| III | 101 (12.5%) |
| IV | 31 (3.8%) |
| V | 157 (19.4%) |
| VI | 256 (31.6%) |
| VII | 77 (9.5%) |
| VIII | 75 (9.3%) |
| IX | 47 (5.8%) |
| X | 60 (7.4%) |
| XI | 29 (3.6%) |
| XII | 59 (7.3%) |
| Multiple | 164 (20.2%) |
| Histopathological Types (n = 579) | No. (%) |
| Conventional | 501 (86.5%) |
| Myxoid | 44 (7.6%) |
| Mesenchymal | 32 (5.5%) |
| Undifferentiated | 2 (0.3%) |
| WHO Grade (n = 928) | No. (%) |
| I/Low | 556 (59.9%) |
| II/Intermediate | 349 (37.6%) |
| III/High | 23 (2.5%) |